US$ 25.09
burping with glp-1 Indigestion from Injections GLP-1 Side Effect Relief –
Description
The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

Semaglutide has been shown to aid in weight loss by helping individuals feel fuller for longer and reducing cravings
GLP-1 medications require specific temperature storage to maintain potency and safety

Book a telemed consultation today with CHRONOS!
